Acute pancreatitis (AP) is one of the most common disorders of the gastrointestinal tract to result in hospitalization. Although most patients with AP will experience an uneventful disease course, those that develop moderate-to-severe AP can be challenging to manage.
[lire la quatrième du livre Acute and Recurrent Pancreatitis]
Technology is changing how we practice medicine. Sensors and wearables are getting smaller and cheaper, and algorithms are becoming powerful enough to predict medical outcomes. Yet despite rapid advances, healthcare lags behind other industries in truly putting these technologies to use.
[lire la quatrième du livre Digital Medicine]
Gene therapy has emerged as a discipline in medicine that can provide treatments for diseases that have no other therapies available, save lives of patients for whom there is no other hope and replace suboptimal treatments with lasting cures.
[lire la quatrième du livre Gene therapy]
Thrombotic thrombocytopenic purpura (TTP) is a rare disorder of the blood coagulation system. In most cases, a lack of the ADAMTS13 enzyme leads to an accumulation of ultra-large von Willebrand factor molecules in the plasma which, in turn, initiate the formation of microscopic thromboses in small blood vessels. TTP is a medical emergency.
[lire la quatrième du livre Thrombotic Thrombocytopenic Purpura]
Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics.
[lire la quatrième du livre Biosimilars in Hematology and Oncology]
A diagnosis of amyotrophic lateral sclerosis (also known as Lou Gehrig’s disease or motor neuron disease) is a progressive neurodegenerative disorder that exerts a notorious life-shortening physical toll.
[lire la quatrième du livre Diagnosing amyotrophic lateral sclerosis]
The peripheral T-cell lymphomas (PTCLs) are a heterogenous group of rare entities. Whilst cytogenetic and molecular identifiers are being identified, accurate diagnosis remains challenging, requiring careful, expert integration of the clinical and pathological findings.
The treatment of PTCL is also challenging.
[lire la quatrième du livre Peripheral T-cell Lymphoma]
This last year has seen the approval of the first targeted treatments for acute myeloid leukemia (AML) - following decades with no new developments and a poor prognosis for most patients with the disease.
[lire la quatrième du livre Acute myeloid leukemia]
